Announcements
15 May 2026
Nutrients 2026—Clinical Nutrition: From Research to Practice—Submissions Approaching & Plenary Speaker Announcement, 22–24 October 2026, Barcelona, Spain
27 January 2026
Meet Us at the 5th Molecules Medicinal Chemistry Symposium, 14–17 May 2026, Beijing, China
23 July 2025
Nutrients 2026—Clinical Nutrition: From Research to Practice—Open for Submissions
2 June 2026
Biomedicines Webinar | Advances in Biomarker Discovery for Cardiovascular Disease, 29 May 2026
Message from the webinar Chair:
Hi everyone, welcome to today’s webinar on “Advances in Biomarker Discovery for Cardiovascular Disease.” This webinar is organized by Biomedicines (ISSN: 2227-9059).
We are honored to have three excellent speakers with us today: Dr. Mitra Esfandiarei, Dr. Elena Galli, and Dr. Katharina Wassilew.
Dr. Esfandiarei is a Research Professor in Basic Medical Sciences at the University of Arizona. She also serves as an Affiliated Professor in anesthesiology, pharmacology, and therapeutics at the University of British Columbia.
Dr. Galli is currently a researcher at the Institute of Image, IHU Strasbourg, and previously served as a Full Professor of cardiology at the Université de Strasbourg.
Dr. Wassilew is currently a Researcher at Institute of Information and Communication Technologies, Bulgarian Academy of Sciences. Previous appointments include an Associate Professor position at one of the largest faculties for health and medical sciences in Europe.
We will have a Q&A session at the end of the webinar. Please feel free to submit your questions in the Q&A box, and our speakers will address them after the presentations.
Date: 29 May 2026 at 17:00 (CEST) | 11:00 (EDT)
Webinar ID: 869 4596 4800
Register now for free!
Program:
| Speaker/Presentation | Time in CEST | Time in EDT |
| Ana Manojlovic Journal Introduction and Overview of Submission Process |
17:00–17:10 | 11:00–11:10 |
| Dr. Qin Fu Chair Introduction |
17:10–17:20 | 11:10–11:20 |
| Prof. Dr. Mitra Esfandiarei Unlocking Endothelial Potential: Endothelial Function as a Catalyst for Aortic Root Aneurysm Protection in Marfan Syndrome |
17:20–17:40 | 11:20–11:40 |
| Prof. Dr. Elena Galli Presentation |
17:40–18:00 | 11:40–12:00 |
| Dr. Katharina Wassilew Cardiovascular Biomarkers Associated with Inflammation - a Pathologists' Perspective |
18:00–18:20 | 12:00–12:20 |
| Q&A Session | 18:00–18:15 | 12:00–12:15 |
| Dr. Qin Fu Closing of Webinar | 18:15–18:20 | 12:15–12:20 |
After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? You can register anyway, and we will let you know when the recording is available to watch.
Webinar Chair and Keynote Speakers:
- Dr. Qin Fu, Cornell University, USA;
- Prof. Dr. Mitra Esfandiarei, University of Arizona, USA;
- Prof. Dr. Elena Galli, CNRS-University of Strasbourg, France.
Relevant Special Issue:
“Advances in Biomarker Discovery for Cardiovascular Disease—2nd Edition”
Guest Editors: Maciej Walędziak and Anna Maria Różańska-Walędziak
Deadline for manuscript submissions: 30 September 2026
1 June 2026
Biomedicines Webinar | Biomarkers in Metabolic Disorders, Obesity and Type 2 Diabetes Mellitus, 29 May 2026
This webinar focuses on biomarkers linked to metabolic disorders, obesity and type 2 diabetes mellitus. It explores novel molecular indicators for early diagnosis, disease progression monitoring and assessment of therapeutic efficacy. Advanced biomarker research lays a solid foundation for precise prevention strategies and personalized clinical management of prevalent metabolic illnesses.
Date: 29 May 2026 at 14:00 (CEST) | 8:00 (EDT)
Webinar ID: 815 7852 8050
Website: https://sciforum.net/event/Biomedicines-22?subscribe
Register now for free!
Program:
|
Speaker/Presentation |
Time (CEST) |
Time (EDT) |
|
Iulian Vlad Stan Journal Introduction and Overview of Submission Process |
14:10–14:20 |
8:10–8:20 |
|
Prof. Dr. Anna Maria Różańska–Walędziak and Dr. Maciej Walędziak Chair Introduction |
14:10–14:20 |
8:10–8:20 |
|
Prof. Dr. Anna Maria Różańska–Walędziak Pregnancy After Bariatric Surgery |
14:20–14:40 |
8:20–8:40 |
|
Dr. Raquel Mantuaneli Scarel–Caminaga Potential Biomarkers for Type 2 Diabetes Mellitus, Periodontitis, and Dyslipidemia |
14:40–15:00 |
8:40–9:00 |
|
Q&A Session |
15:00–15:15 |
9:00–9:15 |
|
Prof. Dr. Anna Maria Różańska–Walędziak and Dr. Maciej Walędziak Closing of Webinar |
15:15–15:20 |
9:15–9:20 |
After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? You can register anyway, and we will let you know when the recording is available to watch.
Webinar Chairs and Keynote Speakers:
- Prof. Dr. Anna Maria Różańska–Walędziak, Collegium Medicum Cardinal Stefan Wyszynski, Poland;
- Dr. Maciej Walędziak, Military Institute of Medicine—National Research Institute, Poland;
- Dr. Raquel Mantuaneli Scarel–Caminaga, UNESP–São Paulo State University, Brazil.
Relevant Special Issue:
“Biomarkers in Metabolic Disorders, Obesity and Type 2 Diabetes Mellitus—2nd Edition”
Guest Editors: Maciej Walędziak and Anna Maria Różańska–Walędziak
Deadline for manuscript submissions: 31 October 2026
1 June 2026
MDPI INSIGHTS: The CEO’s Letter #35 – 30 Years of Open Science, Open Access Policies, Spain Summit, MMCS 2026 & Antibiotics 2026
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
30 Years of Open Science, Built Together
This month, we officially launched MDPI’s 30th Anniversary campaign and dedicated anniversary website, marking an important milestone in our journey as an open access publisher. What began in 1996 with a single journal and the simple belief that scientific knowledge should be shared openly and freely has grown into a global publishing organization supporting more than 500 journals, 68,000 Editorial Board Members, and millions of researchers worldwide.
The anniversary page, entitled 30 Years of Open Science, Built Together, reflects on the people, milestones, and partnerships that have shaped MDPI over the past three decades. It includes a retrospective of our development, key moments in the evolution of open access, landmark research articles, journal anniversaries, an interview with the CEO, and perspectives from colleagues and partners who have contributed to our success.
Looking back, one of the most striking aspects of our journey is not simply our growth, but the broader transformation of scholarly publishing itself.
Open access has moved from a niche concept to a widely adopted publishing model, helping make research more accessible, discoverable, and impactful for researchers, institutions, policymakers, and society.
MDPI has been part of this transition and continues to invest in the people, technology, partnerships, and research integrity infrastructure needed to support high-quality open science at scale.
While anniversaries naturally encourage reflection, they are also an opportunity to look ahead. The challenges facing scholarly publishing today, including research integrity, artificial intelligence, accessibility, and global participation in science, will require continued collaboration across the research ecosystem. As we celebrate 30 years of publishing, our focus remains on supporting researchers, strengthening trust in open science, and helping shape the future of scholarly communication together.
I encourage you to visit the anniversary page, explore the milestones, and take a moment to reflect on the role each of us has played in contributing to MDPI’s story.
Thank you for being part of this journey.
Impactful Research
Highlights from MMCS 2026 in Beijing (14-17 May)
From 14–17 May, MDPI hosted The 5th Molecules Medicinal Chemistry Symposium (MMCS 2026) in Beijing, China, bringing together academia and industry to explore advances in chemical biology, medicinal chemistry, and drug discovery.
The conference hosted more than 230 attendees from 37 countries and regions, alongside 257 submissions and 145 accepted abstracts. With a significant increase in attendance – up by 100 participants compared with the previous edition – the popularity of MMCS continues to grow in terms of its international profile and scientific relevance within this rapidly evolving field.
The scientific program covered seven themes:
- Chemical Biology for Drug Discovery
- Medicinal Chemistry Research Progress
- Natural Products in Drug Discovery
- AI-enabled Drug Discovery
- GPCR & Ion Channel Targeted Drug Development
- Innovative Proximity-Based Drug Modalities
- Biocatalysis for Natural Product & Drug Synthesis
The event featured three plenary speakers, 14 keynote speakers, 35 selected oral presentations, and 98 poster presentations, creating opportunities for open scientific exchange and collaboration. Conference Chair Prof. Dr. Diego Muñoz-Torrero described this edition as one of the most successful MMCS events to date.
|
|
|
Thanks to our Sponsors
MMCS 2026 secured sponsorship support from 12 industrial partners, 11 of which set up on-site exhibition booths. Covering biopharmaceutical R&D, life science supplies, pharmaceutical experimental instruments, and industrial service sectors, exhibitors were able to connect their businesses directly with attendees and make connections at the conference.
30th Anniversary Celebration of Molecules
During the conference, we also celebrated the 30th anniversary of Molecules, one of MDPI’s flagship journals. The celebration brought together Section Editors-in-Chief, Editorial Board Members, MDPI leadership, and editorial colleagues to reflect on the journal’s development, achievements, and continued future growth.
Events such as MMCS 2026 highlight the important role conferences play in creating scientific exchange and collaboration, and in connecting our research communities in person.
They also reflect the continued development of MDPI’s conference portfolio and our commitment to supporting academic engagement beyond publishing alone. Thanks to everyone involved in organizing and contributing to the success of this event.
Inside MDPI
Open Access Policies Continue to Accelerate Globally
One of the clearest indicators of the continued momentum behind open access is the growing number of national and institutional policies supporting, and increasingly requiring, open dissemination of research.
Around the world, governments, funding agencies, and universities are building their open access mandates, with increasing focus on transparency, rights retention, and public accessibility of publicly funded research. While these policies vary across regions, the broader direction is clear: expectations around openness and compliance continue to accelerate.
For researchers, navigating these evolving requirements can be complex and time-consuming. Supporting the research community therefore means not only publishing high-quality open access content but also helping stakeholders better understand changing requirements and emerging opportunities. At MDPI, we see this as an important part of our role within scholarly communication.
“Expectations around openness and compliance continue to accelerate”
Through the MDPI Blog, our Content team continues to publish monthly articles overviewing different countries’ relationships with open access, exploring their histories, policies, opportunities, and statistics. All this information is centralized into an article which contains brief summaries of each country, with links to all the full articles, and is updated monthly.
Recent Policy Developments
South Africa
In 2026, South Africa’s Department of Science and Innovation introduced the South African Open Science Policy. The policy states that: “Open access shall be required for publications arising from publicly funded research, and desirable for research from all sources of funding.”
The policy envisions a coordinated and broad approach to open science that will sustainably and ethically drive socio-economic development by increasing the practice of open science through policy, training, incentivization, and infrastructure.
Canada
In Canada, the Tri-Agency OA Policy on Publications was revised, removing the 12-month embargo for research that must be deposited in a repository with an open license and with author rights retained.
The Agencies argue that “societal advancement is made possible through widespread and barrier-free access to cutting-edge research and knowledge.”
Chile
Chile is a collaborative and engaged member of the global open access movement.
The National Research and Development Agency (Agencia Nacional de Investigación y Desarrollo, or ANID) is Chile’s main funding agency for R&D. It mandates that all beneficiaries must deposit the final version of their published scientific output, with an embargo period of up to 12 months, into a repository.
ANID also supports the InES Open Science funding program, which allows universities to request funding for capacity and infrastructure building. Further, Chile is an active participant in various international initiatives, such as Redalyc, SciELO, and Red de Repositorios Latinoamericanos.
Openness Beyond Research
At MDPI, openness remains one of our core values, ensuring that research outputs are freely accessible to anyone. This commitment also extends to sharing knowledge about the scholarly publishing landscape itself, which we practice on the MDPI Blog through various topics, including open access, recent advances in science, and opportunities for researchers.
As the open access landscape continues to evolve, helping researchers, institutions, editors, and partners navigate these changes will remain an important priority for us.
Thank You
I would like to thank Jack McKenna (Senior Content Specialist, MDPI) from our Content team for his ongoing work on the MDPI Blog series covering global open access policy developments. Initiatives such as this help make complex policy discussions more accessible and useful to the wider research community.
Coming Together for Science
Reflections from the MDPI Spain Summit 2026 in Valencia (21 May)
On 21 May, we hosted the MDPI Spain Summit 2026 in Valencia.
The Summit brought together 30 Editorial Board Members and MDPI colleagues for a discussions on the future of publishing, research integrity, peer review, artificial intelligence, and the evolving research landscape in Spain.
We hosted participants from leading Spanish institutions and spoke on the importance of Spain as a major contributor to global open access (OA) research. In 2025 alone, Spain ranked among the leading countries worldwide for OA publishing, with more than 85% of publications made openly accessible. MDPI also continues to play a significant role within the Spanish research ecosystem.
MDPI in Spain
Spain remains one of MDPI's most important academic markets and a leading contributor to OA research globally. Ever since our Barcelona office opened in 2016 (Happy 10th Anniversary!), MDPI Spain has been actively supporting researchers, institutions, societies, and academic partners across the country. Today, the office plays an important role in creating engagement with the Spanish scholarly community through editorial support, partnerships, conferences, training initiatives, and outreach activities.
A cluster of high-level indicators highlight both the strength of the local research ecosystem and MDPI’s role within it:
- 43,218 total publications in Spain in 2025, of which 35,728 (83%) were open access (49% Gold OA).
- 211,200+ total publications (2021–2025), with 84% published open access.
- 13,444 MDPI publications from Spanish institutions in 2025, representing 14% of all open access publications in Spain.
- More than115,100 MDPI publications from Spanish institutions since 1996.
- More than 4,500 Editorial Board Members from Spain, including more than 150 Chief Editors and 57 Associate Editors.
- 42 institutional partners participating in MDPI’s Institutional Open Access Program (IOAP).
- Spain ranks second globally for MDPI society affiliations, with 26 affiliated society agreements currently in place.
Program Overview
What made this summit special was the openness of the discussions around the research landscape in Spain and the role MDPI plays within the market. General topics of the presentations included:
- MDPI Introduction – Stefan Tochev (CEO).
- Engagement with the Academic Community – Dr. Marta Colomer (External Affairs Lead).
- Latest Developments in the Editorial Process – Dr. Jordi Martinez (Deputy Managing Editor).
- Research integrity and Publication Ethics – Slavomir Nikodijevic (Research Integrity Specialist).
- A 360 View of Academic Publishing – Prof. Dr. Luis Angel Ruiz Fernandez (EBM of Remote Sensing).
|
|
|
|
|
|
|
|
Panel Discussion
We also hosted a panel discussion moderated by Marta, entitled “The Future of Academic Publishing” with Prof. Luis Ruiz, Prof. Marta Feliz (EBM of the journal Catalysts), Dr. Enric Sayas (Product Owner, AI & Technology Innovation), and myself. The discussion looked at the evolving role of editors, the future of peer review, and the growing importance of maintaining trust, ethics, and research integrity in an era increasingly influenced by artificial intelligence.
|
|
|
|
Themes from the Summit
Several themes emerged throughout the discussions, reflecting broader conversations taking place across publishing:
- The academic community values efficient publishing workflows, but expectations around scientific quality and editorial rigor continue to rise.
- Reviewer fatigue and long-term sustainability of peer review remain major challenges across the industry.
- AI is rapidly changing scholarly communication and requires transparent and responsible governance.
- Reputation and trust continue to depend on long-term engagement, transparency, and quality-focused decision-making.
“Maintaining an open dialogue with researchers, editors, reviewers, and institutions remains a priority for MDPI”
It was constructive to see the willingness of participants to engage directly and candidly with us. These conversations provide insights that help inform how we continue to develop our editorial processes, engagement activities, and support for the research community. While certain discussions included concerns, there was also recognition that open dialogue between publishers and the research community is essential if we want to improve scholarly communication together.
|
|
|
|
Events such as this are increasingly important for MDPI. They allow us to present our perspective, to listen to the experiences, expectations, and concerns of editors, reviewers, and researchers, and to address these accordingly.
Thank You
Thank you to our Barcelona Office and all colleagues involved in organizing the summit, as well as all participants for contributing to these thoughtful and constructive discussions.
|
|
|
|
|
|
|
|
As publishing continues to evolve, maintaining an open dialogue with researchers, editors, reviewers, and institutions remains an important priority for MDPI. Events such as the Spain Summit play an important role in helping us to build relationships, foster trust, and better understand the needs of our community.
Closing Thoughts
Highlights from Antibiotics 2026 in Barcelona (11–14 May)
This week, MDPI hosted the Antibiotics 2026 — Advances in Antimicrobial Action and Resistance conference in Barcelona, bringing together academics and industry experts to discuss one of the most important scientific and public health challenges of our time: antimicrobial resistance.
The conference welcomed 145 attendees from 42 different countries and territories, alongside 265 submissions and 127 accepted abstracts, showing the international reach of the event and the strong scientific interest in this rapidly evolving field.
Scientific Exchange on a Global Challenge
Antimicrobial resistance continues to be a global concern, creating collaboration across disciplines, institutions, and regions. The conference program focused on a range of topics including:
- Antimicrobial resistance mechanisms
- One Health approaches to antimicrobial stewardship
- Discovery of novel antimicrobial agents
- Innovation in clinical strategies and treatment approaches
- Ethnopharmacology and emerging therapies
Through keynote plenaries, invited lectures, oral presentations, and poster sessions, the conference created a platform for dialogue and scientific exchange.
|
|
|
International Participation and Collaboration
One of the highlights of the event was the diversity of participation across both geography and expertise. Researchers and speakers from Europe, North America, Asia, Africa, Australia, and Latin America took part in discussions throughout the conference, highlighting the global nature of both the challenge and the scientific response.
The scientific program included:
- 2 keynote speakers
- 10 invited speakers
- 36 selected talks
- 78 posters
The conference brought together perspectives from academia, healthcare, and industry, helping facilitate interdisciplinary collaboration around future approaches to antimicrobial research and resistance management.
|
|
|
|
The Role of Conferences in Scholarly Communication
Conferences are an important platform for collaboration, scientific exchange, and community-building. Events such as Antibiotics 2026 show the value of bringing researchers together in person to discuss emerging challenges, share new findings, and strengthen international networks across disciplines and regions.
Thank You
I would like to thank the conference chairs, speakers, participants, sponsors, and the entire MDPI conference team for their work in making this event a success. The engagement and positive feedback from attendees highlight the importance of our events in addressing some of the most pressing scientific challenges facing society today.
Chief Executive Officer
MDPI AG
29 May 2026
Meet Us at the 32nd Federation of Asian and Oceanian Biochemists and Molecular Biologists (FAOBMB) Conference, 10–13 August 2026, Hong Kong, China
27 May 2026
Biomedicines Webinar | Biomedicines Reviewer Club 2026, 10 June 2026
Welcome to our Biomedicines Reviewer Club 2026. We are pleased to host this ceremony to thank the exceptional and outstanding reviewers for their efforts and to present this roundtable discussion to further explore peer review and future trends in biomedical research.
In recent years, scholarly publishing has witnessed profound transformations. The demand for greater transparency and efficiency in peer review continues to grow, even as publication volumes surge and the reviewer pool faces increasing pressure. In response, innovative approaches have emerged to streamline processes and better align them with authors' needs. The integration of artificial intelligence tools, for instance, is gradually automating administrative tasks, enabling reviewers to focus on the most critical aspects of evaluation. While these shifts are reshaping the publishing ecosystem, the core value of peer review remains unchanged: it is the primary mechanism for ensuring the rigor, credibility, and impact of scientific research.
At the same time, biomedical research itself is undergoing a paradigm shift. Breakthroughs in technologies such as single-cell sequencing, spatial transcriptomics, and advanced imaging are providing unprecedented insights into disease mechanisms. Emerging fields like organoid engineering, CRISPR-based therapies, and mRNA vaccines are redefining what is possible in personalized medicine.
Join us for this roundtable discussion where our distinguished panelists will share their experiences and insights into the peer review process and the biomedical research landscape.
Date: 10 June 2026
Time: 2:00 p.m. CEST | 8:00 a.m. EDT | 8:00 p.m. CST Asia
Webinar ID: 830 3964 5862
Website: https://sciforum.net/event/Biomedicines-23?subscribe
Register now for free!
Program:
| Speaker/Presentation | Time in CEST | Time in EDT | Time in CST Asia |
| MDPI Host—Iulian Vlad Stan Opening Remarks |
2:00–2:10 p.m. | 8:00–8:10 a.m. | 8:00–8:10 p.m. |
| Prof. Dr. Felipe Fregni Award Ceremony |
2:10–2:30 p.m. | 8:10–8:30 a.m. | 8:10–8:30 p.m. |
| Roundtable Discussion Transforming Peer Review: Innovations and Emerging Technologies |
2:30–3:00 p.m. | 8:30–9:00 a.m. | 8:30–9:00 p.m. |
| Roundtable Discussion Charting the Future: Breakthroughs and Long-Term Impacts in Biomedical Research |
3:00–3:30 p.m. | 9:00–9:30 a.m. | 9:00–9:30 p.m. |
| Q&A Session | 3:30–3:45 p.m. | 9:30–9:45 a.m. | 9:30–9:45 p.m. |
| MDPI Host—Iulian Vlad Stan Closing of Webinar |
3:45–3:50 p.m. | 9:45–9:50 a.m. | 9:45–9:50 p.m. |
After registering, you will receive a confirmation email outlining how to join this webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway, and we will let you know when the recording is available to watch.
Webinar Chair and Speaker:
- Prof. Dr. Felipe Fregni, 1 Neuromodulation Center and Center for Clinical Research Learning, Spaulding Rehabilitation Hospital and Massachusetts General Hospital, Harvard Medical School; 2 Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Speakers:
- Prof. Dr. Philip Calder, Faculty of Medicine, University of Southampton, Southampton, UK;
- Dr. Nicoletta Cera, Faculty of Psychology and Education Sciences, University of Porto, Portugal;
- Dr. Marcin Kurowski, Department of Immunology, Rheumatology and Allergy, Medical University of Łódź, Poland;
- Dr. Paweł Nadziakiewicz, Department of Anesthesiology and Intensive Therapy, Silesian Centre for Heart Diseases, Medical University of Silesia, Katowice, Poland.
26 May 2026
MDPI Canada & USA | Summary of an MDPI Subject Workshop—Cutting-Edge Advances in Cancer Immunology and Immunotherapy: From Basic Science to Clinical Impact
On 8 May 2026, MDPI Canada & USA welcomed over 40 researchers, clinicians, and oncology professionals to our Subject Workshop, “Cutting-Edge Advances in Cancer Immunology and Immunotherapy: From Basic Science to Clinical Impact”, held at the HSC Conference Center in Los Angeles, California.
 |
Our workshop host, Bob Vrooman, Head of Business Development at MDPI USA, opened the event and emphasized the importance of advancing cancer care. He introduced the workshop chair, Dr. W. Martin Kast, highlighting his achievements in immunology and cancer research. |
 |
Dr. W. Martin Kast welcomed attendees, emphasizing the transformative impact of cancer immunotherapy and the challenges that remain. |
 |
Then, MDPI Canada & USA’s Operating Director, Elvis Wang, emphasized the company's core values of transparency, service, and integrity. Furthermore, he explained the importance of collaboration in scientific research. |
The day’s presentations were full of exciting discussion as ten speakers discussed their research findings. These presenters included Dr. Abhinava Mishra, Dr. Alan L. Epstein, Dr. De-Chen Lin, Dr. Casey O’Connell, Dr. Henry K. Wong, Dr. Hossein Jadvar, Dr. Kawaljit Kaur, Dr. Lili Yang, Dr. W. Martin Kast, and Dr. Sonia Sharma.
The presentations included topics such as immune checkpoint blockade therapy, CAR-T and CAR-macrophage therapies, and the role of NK cells in cancer therapy. Furthermore, presentations focused on how epigenetic mutations reshape T-cell behavior.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
The second half of the day included presentations covering imaging treatment response criteria and multimodal single-cell analysis. Further presentations focused on the treatment of cutaneous T-cell lymphomas (CTCLs) and the development of therapeutic vaccines to treat HPV-associated cancers.
Dr. Sheridan Baker, a representative of MDPI, covered MDPI's role in supporting open science and MDPI’s publishing trends in oncology. His presentation allowed audience members to further understand how MDPI can support researchers working within a variety of research areas.
 |
 |
During the day’s proceedings, multiple Q&A sessions were held, allowing valuable engagement between speakers and attendees. These sessions were a highlight of the event and helped build a platform for meaningful scientific exchange.
 |
 |
 |
 |
Looking Ahead
The MDPI 2026 LA Subject Workshop “Cutting-Edge Advances in Cancer Immunology and Immunotherapy: From Basic Science to Clinical Impact” was a successful collaboration between MDPI and local academics. We are thankful to all attendees for their part in making this event possible and for contributing to its success.
We have received positive feedback regarding this event and look forward to continuing to host these Subject Workshops. For more updates regarding this event and other upcoming workshops, follow MDPI Canada on LinkedIn.
 |
 |
22 May 2026
Meet Us at the Alzheimer's Association International Conference 2026 (AAIC), 12−15 July 2026, London, UK
